| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-06 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.12 | 5e-05 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.13 | 9e-05 |